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Abstract
Equine recurrent uveitis is a spontaneous, lymphocyte-driven autoimmune disease. It affects horses worldwide and presents
with painful remitting-relapsing inflammatory attacks of inner eye structures eventually leading to blindness. Since
lymphocytes are the key players in equine recurrent uveitis, we were interested in potential changes of their protein
repertoire which may be involved in disease pathogenesis. To create a reference for differential proteome analysis, we first
unraveled the equine lymphocyte proteome by two-dimensional sodium dodecyl sulfate - polyacrylamide gel
electrophoresis and subsequently identified 352 protein spots. Next, we compared lymphocytes from ERU cases and
healthy horses with a two-dimensional fluorescence difference in gel electrophoresis approach. With this technique, we
identified seven differentially expressed proteins between conditions. One of the significantly lower expressed candidates,
septin 7, plays a role in regulation of cell shape, motility and migration. Further analyses revealed T cells as the main cell
type with decreased septin 7 abundance in equine recurrent uveitis. These findings point to a possible pathogenetic role of
septin 7 in this sight-threatening disease.
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Introduction
Equine recurrent uveitis (ERU) is a highly prevalent disease in
horses and presents with spontaneously occurring, painful
remitting-relapsing inflammation of inner eye structures [1]. Prior
to an uveitic attack, activated peripheral-blood derived lympho-
cytes infiltrate the eye by crossing the blood-retinal barrier and
destruct their main target, the retina [2–4]. With every subsequent
relapsing inflammatory phase, lymphocyte infiltration from
periphery reoccurs and inflammation increases in severity
eventually leading to blindness [5]. Not only does this organ-
specific autoimmune disease have severe, sometimes fatal conse-
quences for diseased horses, it is also the only spontaneous model
for relapsing autoimmune uveitis in man, due to remarkable
clinical and immunopathological similarities [6]. Although it is
known that in ERU, autoaggressive lymphocytes are predomi-
nantly targeted against retinal autoantigens [2,7–9] and epitope
spreading is a possible explanation for remitting-relapsing
character of disease [10], underlying molecular mechanisms
affecting lymphocyte function in ERU are still elusive. Changes
in protein expression pattern of these immune cells might be a
potential indicator for altered lymphocyte function contributing to
pathogenesis. Since autoaggressive lymphocytes are present in
peripheral blood directly before onset of an uveitic attack [10],
differential proteome analysis of peripheral blood-derived lym-
phocytes in ERU is a valuable technique to gain further insights
into these pathological processes. To create a solid basis for these
analyses, however, knowledge of the equine lymphocyte protein
repertoire is essential. Therefore, we unraveled the equine
lymphocyte proteome and subsequently used two-dimensional
fluorescence difference in gel electrophoresis (2D-DIGE) to screen
the lymphocyte proteome for differences in protein abundance
comparing peripheral lymphocytes of healthy horses and ERU
cases. Taken together, this study aimed at finding differentially
expressed proteins which might affect lymphocyte function and
thereby contributing to pathogenesis of ERU.
Materials and Methods
Ethics statement
No experimental animals were used in this study. Horses were
treated according to the ethical principles and guidelines for
scientific experiments on animals according to the ARVO
statement for the use of animals in Ophthalmic and Vision
research. Blood from ERU horses was withdrawn as part of
patient’s diagnostics. Withdrawal of blood samples from healthy
horses was permitted by the local authority (Regierung von
Oberbayern; permit number: AZ 55.2-1-54-2532.3-21-12).
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Selection of animals used in the study
All ERU diseased horses were those brought to the Equine
Clinic of the LMU Munich. ERU was diagnosed by clinical signs
of acute uveitis accompanied by a documented history of
recurrent eye inflammation. Horses with ERU included in this
study had had at least three uveitic attacks. Blood from ERU
cases was withdrawn prior to therapeutic pars plana vitrectomy,
in quiescent stage of disease. The horses used in this study
received topical medication solely to the eye, if at all, but did not
receive systemical medication. Therefore, no influence was taken
through treatment on the peripheral lymphocyte population
investigated. Healthy horses used as controls were matched in sex
and age.
Sample preparation
Lymphocytes from 29 healthy horses and 27 ERU cases were
examined in this study. In detail, peripheral blood derived
lymphocytes (PBL) of 1 healthy horse were used for two-
dimensional lymphocyte proteome reference map, 5 healthy
controls and 5 ERU diseased horses were used for 2D-DIGE
screening experiment. For Western blot analysis, lymphocytes of
12 healthy controls and 11 ERU cases were used. PBL from 11
healthy horses and 11 ERU cases were analyzed by flow
cytometry. All blood samples from ERU diseased horses were
obtained from the Equine Clinic in Munich without prior selection
for a respective experimental condition (DIGE profiling, Western
blot verification, flow cytometry). Diseased and healthy horses
were matched in age and sex for DIGE screening experiments.
Equine venous blood was collected in lithium-heparin coated tubes
(Kabe, Nümbrecht-Elsenroth, Germany). After rough sedimenta-
tion of erythrocytes, lymphocytes were isolated from plasma by
density gradient centrifugation (room temperature (RT), 290
relative centrifugal force (rcf), 25 min, brake off) using Biocoll
separating solution (Biochrom, Berlin, Germany). Lymphocytes
were extracted from intermediate phase, washed twice in PBS
(4uC, 453 rcf, 10 min) and number of lymphocytes was counted to
ensure comparable sample composition for further analyses. Cells
were then either used immediately or stored at 220uC (pellet) or
280uC (vital cells, cryopreservated).
Two-dimensional separation of the equine lymphocyte
proteome
PBL of a healthy horse were dissolved in lysis buffer (9 M
Urea, 2 M Thiourea, 1% Dithioerythritol, 4% CHAPS, 2.5 mM
EDTA) and processed using QIAshredder homogenizers (Qia-
gen, Hilden, Germany) for depletion of DNA precipitates.
Protein content of cell lysates was determined by Bradford
protein assay (Sigma-Aldrich, Deisenhofen, Germany). One mg
of lysate was loaded on 24 cm pH 3-11 NL IPG strips (GE
Healthcare, Freiburg, Germany) by overnight reswelling and
subjected to isoelectric focusing (IEF) on a 2117 Multiphor II
Electrophoresis Unit with an Amersham Electrophoresis Power
Supply EPS 3501 XL (Step 1: 2 h/50 V/2 mA/5 W, Step2:
11 h/600 V/10 mA/10 W, Step 3: 4 h/2000 V/10 mA/10 W,
Step 4: 12 h/3000 V/10 mA/10 W). Strips were then equili-
brated in 1% Dithiothreitol followed by 4.8% Iodoacetamide for
10 minutes each and sodium dodecyl sulfate - polyacrylamide gel
electrophoresis (SDS-PAGE) was subsequently performed in an
Ettan DALT Six Electrophoresis Unit 230 (GE Healthcare) with
an Amersham Electrophoresis Power Supply EPS 3501 XL (Step
1: 45 min/600 V/150 mA/9 W, Step 2: 1 h/850 V/300 mA/
60 W, Step 3: 8 h/1000 V/400 mA/90 W). Resulting gels were
colloidal coomassie stained and scanned on a transmission
scanner. As many spots as possible were cut from gels and
processed for mass spectrometry.
Two-dimensional fluorescence difference in gel
electrophoresis (2D-DIGE)
Approximately 16108 PBL of 5 ERU diseased horses and 5
controls each were dissolved in DIGE lysis buffer (7 M Urea, 2 M
Thiourea, 4% CHAPS, 30 mM Tris; pH 8.5) and processed using
QIAshredder homogenizers for depletion of DNA precipitates
(Qiagen). 50 mg protein of each sample was labeled separately with
400 pmol Cy3 or Cy5 fluorescent CyDyes (GE Healthcare)
according to minimal labeling technique. To exclude possible
dye-specific effects of labeling on one group, we applied reverse
labeling technique, labeling 2 control PBL lysates with Cy3 and 3
controls with Cy5 and vice versa in ERU cases. Additionally, a
pooled internal standard containing all 10 samples used in the
experiment was labeled with Cy2 (GE Healthcare). Labeling of
proteins at 4uC was terminated after 30 min by addition of lysine.
After 10 minutes of incubation, samples were pooled into sets,
each comprising three differently dyed 50 mg aliquots (diseased/
control/internal standard). The 150 mg protein compounds were
adjusted to a volume of 460 ml with lysis buffer, loaded on 24 cm
pH 3–11 NL IPG strips (GE Healthcare) and subjected to IEF
followed by equilibration and SDS-PAGE. Resulting gels were first
scanned at different wavelengths (488 nm for Cy2, 532 nm for
Cy3, 633 nm for Cy5 labeled proteins) with Typhoon Trio69
Scanner (GE Healthcare) and then silver stained for visualization
of protein spots.
Image analysis and detection of differentially expressed
proteins (DeCyder software)
Data of scanned DIGE gels were imported into DeCyder 6.5
software (GE Healthcare) and processed in DIA module for
separate analysis of each gel (intra gel analysis), comprising the
assignment of dye tag to images (internal standard: Cy2, control:
Cy3 or Cy5, diseased: Cy5 or Cy3 due to reverse labeling), spot
detection and normalization of Cy3 and Cy5 labeled spot
abundances to the internal standard as well as comparison of
spot abundances between control and ERU data sets. To avoid
detection of ‘‘false’’ spots, inclusion and exclusion criteria for spot
detection were set at: spot slope .2, spot volume ,30000,
threshold 2.5. After automatic detection and matching of spots by
software analysis was verified manually and corrected if necessary.
In BVA module, standardized protein spot abundances from each
gel data set generated in the experiment were compared (inter gel
analysis), enabling detection of protein abundance differences
between groups. Detected differences in protein abundance were
considered significant at p,0.05 (Student’s t test) and inclusion
criterion for further analysis was a fold change of .1.5.
Differentially abundant protein spots from digital DeCyder map
were located on matching silver stained gels and excised for
subsequent identification by mass spectrometry (MALDI/TOF-
TOF; ABI 4700 Proteomics Analyzer, Applied Biosystems,
Darmstadt, Germany).
Identification of proteins from spotmap as well as
differentially expressed proteins with mass spectrometry
(MALDI-TOF/TOF and LC-MSMS)
Selected spots from 2D-gels were excised manually and silver
stained spots were destained by repetitive washes in water and
buffer containing 30 mM potassium ferricyanide and 100 mM
sodium thiosulfate. Destained spots from silver stained gels as well
as spots from coomassie stained gel were shrunk in 100%
Septin 7 Expression in Equine Recurrent Uveitis
PLOS ONE | www.plosone.org 2 March 2014 | Volume 9 | Issue 3 | e91684
acetonitrile (ACN), rehydrated in 50 mM NH4HCO3 (shrinking
and rehydration was performed twice) and dried in a SpeedVac
centrifuge. Spots were then digested with 0.01 mg/ml trypsin
(Sigma-Aldrich) in 50 mM NH4HCO3 overnight at 37uC. The
supernatant was collected and combined with eluates of subse-
quent elution steps with 80% ACN and 0.1% trifluoroacetic acid
(TFA). The combined eluates were dried in a SpeedVac centrifuge
and dissolved in 50% ACN and 0.1% TFA.
For protein identification with MALDI-TOF/TOF mass
spectrometry, 0.5 ml of a 1:1 mixture of sample and a matrix
solution consisting of 2.5 mg/ml a-cyano-4-hydroxy-cinnamic
acid (Bruker, Bremen, Germany) were spotted on a MALDI
target. Mass spectra were acquired using a Proteomics Analyzer
4700 mass spectrometer (Applied Biosystems). For each MS
spectrum, 2500 laser shots were averaged and processed with
external calibration. Peptide mass fingerprint (PMF) spectra were
not smoothed and background was not subtracted. Monoisotopic
peak masses were automatically determined within the mass
range 800–4000 kDa with a signal to noise ratio minimum set to
5 and the local noise window width m/z 200. Up to eight of the
most intense ion signals with signal to noise ratio above 30 were
selected as precursors for MS/MS acquisition excluding com-
mon trypsin autolysis peaks and matrix ion signals. In MS/MS
positive ion mode 4000 spectra were averaged with 1 kV
collision energy, collision gas air at a pressure of 1.6610-6 torr
and default calibration. Monoisotopic peak masses were auto-
matically determined with a signal to noise ratio minimum set to
10 and the local noise window width m/z 200. Combined PMF
and MS/MS queries were performed using the MASCOT
search engine (Matrix Science, London, UK; http://www.
matrixscience.com) embedded into GPS-Explorer Software
(Applied Biosystems).
LC–MSMS mass spectrometry was performed as previously
described [11]. Briefly, the digested peptides were loaded
automatically to a HPLC system (Thermo Fisher Scientific)
equipped with a nano trap column in 95% buffer A (5% ACN,
0.1% formic acid (FA) in HPLC-grade water) and 5% buffer B
(80% ACN, 0.1% FA in HPLC-grade water). After 5 min, the
peptides were eluted and separated on the analytical column
(75 mm inner diameter615 cm, Acclaim PepMap100 C18,
3 mm, 100 Å, Dionex) by a gradient from 5% to 50% of buffer
B at 300 nl/min flow over 120 min followed by a 5 min gradient
from 50% to 100% buffer B in 5 min. The eluting peptides were
analyzed online in a LTQ OrbitrapXL mass spectrometer
(Thermo Fisher Scientific) coupled to the HPLC system with a
nano spray ion source. The mass spectrometer was operated in
the data-dependent mode to automatically switch between
Orbitrap-MS and LTQ-MS/MS acquisition. Survey full scan
MS spectra (from m/z 200 to 1500) were acquired in the
Orbitrap with high-resolution (60,000 full-width half maximum).
The method used allowed sequential isolation of the most intense
ions (up to ten), depending on signal intensity, for fragmentation
on the linear ion trap using collisional induced dissociation at a
target value of 100,000 ions. High-resolution MS scans in the
Orbitrap and MS/MS scans in the linear ion trap were
performed in parallel. Target peptides already selected for MS
MS/MS were dynamically excluded for 30 s.
MALDI PMF and MSMS spectra as well as LC-MSMS-derived
MS/MS spectra were analyzed using Mascot (version 2.2, Matrix
Science, London, UK; http://www.matrixscience.com), set up to
search the Ensemble Horse protein database (version 2.66,
12722794 residues, 22644 sequences, http://www.ensembl.org)
setting trypsin as digestion enzyme and allowing fragment ion
mass tolerance of 0.3 Da and a parent ion tolerance of 65 ppm for
MALDI analyses. One missed cleavage was allowed and
iodacetamide derivatives of cysteines as stable modifications as
well as oxidation of methionine and deamidation of asparagine
and glutamine as variable modifications were specified for Mascot
searches.
Protein identifications were accepted if the probability based
MOWSE protein score was above the p,0.01 significance
threshold for the database and contained at least two identified
peptides with at least 80.0% probability as specified by the Peptide
Prophet algorithm [12]. Additionally, theoretical isoelectric point
(pI) and molecular weight (Mw) from most search results
correlated to the position of the corresponding spot in the gel.
Proteins that contained similar peptides but could not be
differentiated based on MS/MS analysis alone were grouped to
satisfy the principles of parsimony.
Quantification of septin 7 expression differences
(Western blot)
Lymphocytes were lysed in lysis buffer (9 M Urea, 2 M
Thiourea, 1% Dithioerythritol, 4% CHAPS, 2.5 mM EDTA)
and incubated with laemmli buffer (4% SDS, 20% glycerol,
10% 2-mercaptoethanol, 0.004% bromphenol blue, 0.125 M
Tris; pH 6.8) for 5 minutes at 95uC and 750 rpm on a bench
top shaker. From each sample, 10 mg protein was separated by
SDS-PAGE on 8% gels and blotted semidry onto PVDF
membranes (GE Healthcare). Unspecific binding was blocked
in 1% Polyvinylpyrrolidone with 0.05% Tween20 (PVP-T) for
1 h at room temperature. Blots were incubated with mouse anti-
septin 7 antibody (SantaCruz Biotechnology, Heidelberg,
Germany, 1:1000) at 4uC overnight. Before and after incubation
with HRP-coupled anti-rabbit IgG antibody (Sigma-Aldrich,
1:3000) for 1 h at room temperature, blots were washed in
phosphate buffered saline solution with 0.05% Tween20 (PBS-
T). Signals were detected by enhanced chemiluminescence on
X-ray film (SUPER-2000G ortho, Fuji; Christiansen, Planegg,
Germany). Films were scanned on a transmission scanner and
densitometric quantification of Western blot signals was
performed using ImageQuantTL software (GE Healthcare).
Specific binding of septin 7 antibody to horse septin 7 was
verified with immunoprecipitation and subsequent mass spec-
trometry analysis, clearly identifying equine septin 7 bound by
the antibody. Blots were then incubated in stripping buffer
(100 mM NaOH, 2% SDS, 0.5% DTT) for 1 hour at 55uC,
washed with PBS-T and blocked with 1% PVP-T for 1 hour at
room temperature. After repeated washing with PBS-T, blots
were re-incubated with mouse anti-beta actin antibody (Sigma-
Aldrich; 1:5000) followed by secondary HRP-coupled anti-
mouse IgG antibody (Sigma-Aldrich, 1:5000) and signals were
developed as described above. Subsequently, all septin 7 signal
abundances were normalized to respective beta actin values.
Statistical analysis of septin 7 expression level comparison
between ERU samples and controls was performed using
Student’s t test and differences in protein expression were
considered significant at p,0.05.
Analysis of septin 7 expression differences with flow
cytometry
Equine PBL were isolated from plasma by density gradient
centrifugation as described above. Cell staining was performed
either directly (CD4, CD8, CD21) or after permeabilization of
cells (septin 7) in 96 well roundbottom plates with 16106 cells per
well. Mouse IgG1 anti-equine CD4, mouse IgG1 anti-human
CD21 (both Serotec, Puchheim, Germany, 1:10) and mouse IgG3
Septin 7 Expression in Equine Recurrent Uveitis
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anti-equine CD8a (VMRD, Pullman, Washington, United States,
1:50) antibodies were diluted in staining buffer (1% BSA + 0.001%
NaN3 in PBS) and incubated with cells for 30 minutes at 4uC.
After washing with staining buffer, respective secondary antibodies
were added (anti mouse-IgG1:PE, SantaCruz, 1:200 or anti
mouse-IgG3:PE, Biozol, Eching, Germany, 1:200) and incubated
for 30 min at 4uC. Subsequently, cells were permeabilized (BD
Cytofix/Cytoperm fixation/permeabilization kit; BD Biosciences,
Heidelberg, Germany) and washed twice with staining buffer.
Diluted anti-septin 7 antibody (SantaCruz, 1:50) incubated with
cells for 30 minutes at 4uC. After washing with staining buffer,
anti-rabbit IgG:Alexa488 antibody (Invitrogen, Karlsruhe, Ger-
many, 1:200) was added for 30 minutes at 4uC. Cells were stored
at 4uC in staining buffer with 1% PFA until further processing.
Measurement of cells was performed on FACS Canto II with
FACS Diva 6.1.3 software (both BD Biosciences). Lymphocytes
were gated according to forward scatter (cell size) and side scatter
(intercellular granularity) properties of cells. Compensation was
performed manually. 5000 cells were measured per staining.
Further analysis of flow cytometry data was performed using open
source Flowing Software 2.5.0 (Perttu Terho, Turku Centre for
Biotechnology, Finland).
Results
Two-dimensional separation of the equine lymphocyte
proteome
To analyze the equine lymphocyte protein repertoire, we
separated lymphocytes from healthy horses by 2D-PAGE. High-
resolution protein pattern was made visible by colloidal coomassie
staining (figure S1, representative 2D-gel with lymphocyte
proteome pattern of one healthy horse; a total of 94 2D-PAGE
experiments with different specimen were performed in this study)
and showed single, well-separated protein spots with minimal
streaking. 352 protein spots were unambiguously identified by
mass spectrometry and represented 229 different proteins (figure
S1 and table S1).
Seven proteins show altered expression in ERU
As we were interested in the characterization of lymphocyte
protein expression pattern differences between healthy horses and
ERU cases, we used 2D-DIGE technique for comparative
proteome screening. With this approach, we were able to detect
seven differentially abundant proteins in ERU (Figure 1, figure S2;
p,0.05, fold change .1.5), which could clearly be identified by
mass spectrometry (Table 1). One of these proteins, lactotransfer-
Figure 1. Spot map of equine PBL proteome generated by DeCyder 6.5 software. Protein spots detected on gel after scanning and
processing were encircled in green. Spots with differential abundance between control- and ERU specimen (n = 5 each) were encircled in red and
numbered according to table 1. Spot numbers referring to proteins with higher abundance in ERU were highlighted in grey, those with lower
abundance in ERU are shown in white. Septin 7 spot (No. 7) showed diminished expression in ERU PBL proteome.
doi:10.1371/journal.pone.0091684.g001
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rin, showed higher expression levels in lymphocytes of ERU cases,
whereas six of the identified candidates were lower abundant in
ERU. Among the latter were glyceraldehyde-3-phosphate dehy-
drogenase, protein tyrosine phosphatase non-receptor type6,
voltage-dependent anion-selective channel protein 2, programmed
cell death 6-interacting protein, ezrin and septin 7 (Table 1).
Septin 7 expression in lymphocytes of ERU cases
decreases to 62% of physiological expression level
We decided to further analyze septin 7 (Figure 1, spot no. 7) due
to its role in regulation of cell shape, motility and migration [13].
Spot analysis with DeCyder 6.5 software confirmed statistically
significant differences in spot abundance (Student’s t test p,0.05)
(Figure 2 A–D) with a fold change of 1.9 between conditions
(Table 1, column i). Furthermore, differentially abundant septin 7
spot was detected in every single gel included in analysis (Figure 2,
Graph; Table 1 column h). Subsequently, expression differences of
septin 7 between conditions found with 2D-DIGE technique was
verified with Western blots, quantifying septin 7 abundance in a
cohort of healthy horses (Figure 3, white column, average
expression level set to 100%) in comparison to ERU cases
(Figure 3, grey column). Average expression of septin 7 in ERU
significantly decreased to 62% of expression level in controls, as
determined by statistical analysis (Student’s t test, p,0.05).
Differential septin 7 expression is located in T cells
Since we were interested in expression differences of septin 7 in
lymphocyte subsets, we used flow cytometry for further analysis.
To determine whether septin 7 expression differences were
localized in B cells or T cells, we examined septin 7 expression
in double staining with two T cell markers (CD4 and CD8) and
one B cell marker (CD21) in lymphocyte populations of controls
and ERU cases (Figure 4). Septin 7 was highly expressed in all
lymphocyte subsets of controls (Figure 4 E). In B cells, septin 7
showed no change in expression intensity between conditions
(CD21+ B cells; figure 4 A). In T cells, however, we found a clear
decrease of septin 7 expression in ERU down to 75% (CD4+ T
cells; figure 4 B) and 73% (CD8+ T cells; figure 4 C) of expression
level in healthy specimen. Differences in septin 7 expression on
lymphocyte subsets detected by flow cytometry were not
statistically significant.
Discussion
Equine recurrent uveitis is a lymphocyte-driven organ-specific
autoimmune disease with high prevalence in horses [4,14].
Starting spontaneously, painful inflammatory attacks of the inner
eye alternate with quiescent phases [1]. Through the remitting-
relapsing character of the disease, uveitic attacks become more
and more severe over time and inner eye structures, predom-
inantly the retina, are destroyed [3,5,7]. Up to date, therapy
remains symptomatic, providing only moderate relief [15,16].
Horses in advanced stage of disease often face enucleation of
respective eye. If this involves both eyes, diseased horses have to be
killed. Not only does ERU affect the well-being of the equine
population worldwide, it also serves as the only spontaneous model
for relapsing autoimmune uveitis in man [6] due to striking
immunopathological and clinical resemblance such as comparable
immune reactions to retinal S-antigen [2,17–19], IRBP [7] and
CRALBP [8,9] as well as spontaneous onset of disease with
remitting-relapsing character and unsolved etiology.
Prior to an uveitic attack, autoaggressive lymphocytes infiltrate
the eye by crossing the BRB [20]. These cells can be isolated from
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source for analysis of disease-specific alterations in lymphocytes.
To enable detection of possible protein expression differences in
diseased state, we first needed detailed knowledge about the
physiological protein repertoire of equine lymphocytes. Two-
dimensional gel-based studies on physiological lymphocyte
proteome were performed in several species [21–25], however,
the horse was not analyzed so far. Using 2D SDS PAGE, we
separated, displayed (figure S1) and subsequently identified 352
protein spots from the equine lymphocyte proteome (table S1),
giving us detailed information about the equine lymphocyte
protein repertoire and therefore a solid basis for further differential
proteome analyses in ERU.
Previous gel-based differential proteome studies on lymphocytes
in autoimmune disease by other research groups, such as
rheumatoid arthritis in man and a mouse model for type 1
diabetes, led to the identification of several differentially expressed
proteins speculated to be involved in disease pathogenesis [26,27].
Apart from previous studies in our group concerning granulocytes
in ERU [28,29], however, to our knowledge, there were no gel-
based studies on immune cells in autoimmune uveitis. Hence, with
a comparative 2D-DIGE based screening of the equine lympho-
cyte proteome (Figure 1), we now aimed at finding differences in
protein expression which may act as possible indicators of
pathological abnormalities in lymphocytes of ERU cases. We
decided to use biological, rather than technical replicates for a
screening-study of a disease that occurs spontaneously among a
heterogeneous group of individuals. Hence, we compared five
biological replicates with outbred genetical background from
healthy horses to five replicates from ERU diseased state and
detected seven differentially expressed candidate proteins (Table 1).
Since the individual variation in biological replicates masks the
statistical significance of differential protein expression to a certain
extent, proteins showing differential expression subsequent to this
pre-selection might be especially robust in disease pathogenesis.
However, biomarker candidates for the individual animal are
possibly overlooked using this approach, letting personalized
medicine to the side. Nonetheless, this screening-study resulted in
the identification of a solid amount of differentially expressed
proteins, none of which have been described in association with
spontaneous autoimmune uveitis.
The enzyme glyceraldehyde-3-phosphate dehydrogenase [30]
(figure S1 spot 263 and table 1) was not associated with
autoaggressive lymphocytes so far. Further, this study describes
the first identification of programmed cell death 6-interacting
protein (figure S1 spot 44 and table 1), which may play a role in
the regulation of both apoptosis and cell proliferation [31], as a
downregulated lymphocyte protein in autoimmune disease.
Lactotransferrin (figure S1 spot 13 and table 1) acts as a growth
stimulating factor for lymphocytes [32,33] with favorable effects
on the maturation and differentiation of T cells [34]. This is
interesting regarding the fact that, in present study, higher
expression of lactotransferrin in ERU points to the presence of
activated immune cells. On the contrary, tyrosine-protein phos-
phatase non-receptor type 6 (figure S1 spot 123 and table 1),
involved in signal transduction cascade of immune cells [35], was
decreased in lymphocytes of ERU cases. Interestingly, this protein
also showed decreased expression in T cells from patients with
psoriasis, which led to enhanced inflammatory processes and
autoimmune responses [36], therefore its role in immune cells is an
interesting feature regarding pathogenesis of ERU as well.
Figure 2. Septin 7 expression as detected in 2D-DIGE
experiment. (A, B) Enlarged view of septin 7 spot from DeCyder-
generated spot map. (C, D) Three-dimensional view of septin 7 spot.
(Graph) Comparison of spot abundance on different gels (number of
gels: 5; number of specimen: 10; proteins per gel were paired); spot
highlighted in A–D is displayed in red, internal standard is displayed in
yellow. Septin 7 clearly decreases in diseased state.
doi:10.1371/journal.pone.0091684.g002
Figure 3. Septin 7 expression differences quantified and
verified by Western blot. Septin 7 expression decreases in PBL of
ERU diseased horses (n = 11, grey column, Septin 7 expression reduced
to 62%) compared to PBL of healthy controls (n = 12, white column, set
to 100%). Signal intensities of septin 7 were normalized to beta-actin
abundances obtained after stripping and re-incubation of respective
blots. Statistical analysis was performed using Student’s t test (* p,
0.05). Representative protein signals are shown above respective
columns; upper Septin 7 signal was used for quantification, lower
signal derived from unspecific binding of the antibody to beta actin and
was not included in the analyses.
doi:10.1371/journal.pone.0091684.g003
Septin 7 Expression in Equine Recurrent Uveitis
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Voltage-dependent anion-selective channel protein 2 (figure S1
spot 253 and table 1) is crucial for mitochondrial metabolism
[37,38]. Interestingly, this protein was described as a new
candidate autoantigen for autoimmune uveitis in man [39]. Ezrin
(figure S1 spot 79 and table 1) belongs to the protein family of
cross linkers between the plasma membrane and the cortical
cytoskeleton [40]. Ezrin’s effect on enhanced T cell activation
through changed expression has already been described in studies
on rheumatoid arthritis [26] and humoral immunity [41]. The
impact of its expression differences on disease pathogenesis in
ERU needs to be further investigated in future studies.
In this study, we focused on diminished expression of Septin 7
(Figure 1 spot 7, figure 2, table 1, figure S1 spot 144, figure S2),
due to its involvement in regulation of cell shape and motility
[13,42]. Septin 7 belongs to the evolutionarily conserved group of
GTP-binding and filament-forming proteins originally discovered
in yeast [43,44] and recently described in vertebrates as important
part of the cell division cycle [45]. Not only do septins interact with
the actin cytoskeleton [46] and regulate microtubule stability
within the cell [47], they also seem to coordinate changes in
membrane organization of cells [42]. Septin 7 has a corset-like
function providing cell compression and rigidity [13,48], an
interesting feature regarding pathogenesis of autoimmune disease,
where activated immune cells cross anatomical barriers. Septin 7
was not described in association with autoimmune diseases to date,
however, septin 7 was studied in other diseases such as acute
myeloid leukemia, where septin 6, forming a complex with septins
2 and 7, showed significantly lower expression in the spinal cord of
patients, indicating deficient regulation of cell cycle [49]. In
neurodegenerative disease such as down syndrome, the diminished
expression of septin 7 in diseased brain of human fetuses was
connected to inhibition of synaptogenesis and synaptic function
[50]. In neoplasia, especially in the brain, septin 7 was reported to
be involved in malignant glioma cell growth due to its inhibitory
effect on cell proliferation [51], which may also be of importance
in ERU, where cells with diminished septin 7 expression could be
those proliferating.
In blood-derived lymphocytes from ERU cases, septin 7
expression level decreased to 62% of expression level in controls
(Figures 1+2, table 1; figure 3). Interestingly, further analyses of
septin 7 expression on lymphocytes revealed that T cells are the
predominant cell type with decreased septin 7 abundance in ERU.
We found that septin 7 expression was diminished in both CD4+
and CD8+ lymphocytes (Figure 4 B + C), whereas B cells showed
no expression difference between conditions (Figure 4 A). This
finding is very interesting regarding the fact that, among all
possible immune cells involved in autoimmune uveitis, T cells have
the strongest impact on target tissue [11,52–54]. The differential
expression of septin 7 in these lymphocytes indicates association
with mechanisms in disease pathogenesis. Septin 7 was recently
reported to affect glucose uptake in cells [55]. In this study, 81%
knock-down of septin 7 in podocytes increased their uptake
capacity of glucose by affecting GLUT4 storage vesicle trafficking
[55]. When lymphocytes shift from quiescent to activated state,
their glucose metabolism increases drastically [56,57]. Hence,
decreased expression of septin 7 in T cells of ERU cases might
Figure 4. Characterization of septin 7 expression intensity on lymphocyte subsets by flow cytometry. Mean intensity of septin 7
expression decreases in lymphocyte subsets of ERU cases (n = 11, dark grey curve) compared to controls (n = 11, light grey curve). Histograms of
representative specimen showed unchanged expression in B cells (A + E, CD21). In T cells, septin 7 expression intensity decreased to 75% (B + E, CD4)
and 73% (C + E, CD8) of physiological expression level. Lymphocytes were gated according to forward- and sideward-scatter (D). Respective values of
all 11 healthy and 11 ERU specimen used in this study are shown in graph (E).
doi:10.1371/journal.pone.0091684.g004
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additionally correlate with activated state of T cells in disease. This
is supported by the fact that septin 7 is a potent inhibitor of cell
proliferation [51] and its decrease in expression level may support
inflammatory events in pathogenesis. Interestingly, Tooley et. al.
earlier described altered migration characteristics in septin 7
deficient cells [13]. In respective study, a murine T cell line that
expressed a short hairpin RNA to septin 7 was used, resulting in
over 80% knock-down of septin 7 expression within the cell.
Although this had an impact on coordinated crawling, septin 7
depletion allowed enhanced T cell migration through pores
normally too narrow for passage of cells [13]. Hence, decreased
septin 7 expression in equine lymphocytes of ERU cases might
indicate changes in cytoskeleton and cell rigidity possibly leading
to changes in migration ability. However, further studies are
necessary to analyze possible connection of altered septin 7
expression and transmigration of cells in autoimmune uveitis.
The DIGE technique used as a discovery method in this study
proved to be an effective tool for the detection of changes in the
equine lymphocyte proteome of ERU cases. This was already
shown in previous studies, where we detected differentially
expressed talin 1 in the equine granulocyte proteome in ERU
and subsequently identified its interactors [28,29]. However, this
method deprived us of the analysis of membrane-associated
proteins since these tend to precipitate during IEF and are poorly
soluble in aqueous solutions as those used in 2D-PAGE [58,59].
Gel-free, detergent-based methods are more suitable for the
analysis of this interesting fraction of lymphocyte proteins [11,60]
and will be performed in future studies to complete the analysis of
proteome changes on inflammatory cells in ERU.
The detection of septin 7 downregulation in lymphocytes of
cases with spontaneous autoimmune uveitis is a very interesting
finding in our opinion and its functional pathogenetic role in ERU
merits further analysis. Especially the connection of differences in
septin 7 expression and the activation of autoreactive T cells
deserves detailed studies, not only in peripheral blood-derived
lymphocytes but also in intraocular cells, which accumulate in the
vitreous in course of this sight-threatening disease.
Supporting Information
Figure S1 Representative map of the equine lymphocyte
proteome. Equine lymphocyte proteome of a healthy horse was
separated by 2D-PAGE on 12% SDS gel loaded with 500 mg
lymphocyte protein lysate, stained with colloidal coomassie
(number of total lymphocyte 2D-PAGE experiments performed:
94). 352 protein spots were identified by mass spectrometry.
Numbers of encircled spots correspond to protein identifications
given in table S1.
(TIF)
Figure S2 Differentially expressed proteins of the
equine lymphocyte proteome as detected by DeCyder
6.5 software. (A, B) Enlarged view of protein spot from
DeCyder-generated spot map. (C, D) Three-dimensional view of
protein spot. (Graph) Comparison of spot abundance on different
gels (number of gels: 5; number of specimen: 10); every dot in
graph represents respective protein in a different gel and condition
(proteins per gel were paired), spot highlighted in A-D is displayed
in red, internal standard is displayed in yellow.
(TIF)
Table S1 Protein identifications from equine lympho-
cytes by mass spectrometry. 352 protein spots (representing
229 different proteins) from equine lymphocytes identified by mass
spectrometry; (column A) number of corresponding spot from
master-gel in figure S1, (column B) protein name and (column C)
accession number as listed in Uniprot protein database (www.
uniprot.org), (column D) probability based MOWSE protein score
from MALDI-TOF/TOF analysis; score is -10*Log(P), where P is
the probability that the observed match is a random event. Protein
identifications were accepted if the MOWSE score was above the
p,0.01 significance threshold for the database and contained at
least two identified peptides with at least 80.0% probability as
specified by the Peptide Prophet algorithm. Percentage scores
derived from identification of proteins with LC-MSMS mass
spectrometry describe the percent probability of correct protein
identification as well as the number of peptides sequenced (shown
in parentheses), (column E) Peptide count from MALDI-TOF/
TOF analysis. In comparison to a human lymphocyte proteome
study by Vergara et al., where a total of 246 spots were identified,
representing 174 different proteins [21], we could overall identify
more proteins, however, the general protein pattern and
identifications resemble each other in both species. Several of
the differentially expressed proteins detected in the DIGE
screening experiment (Figure 1 and table 1) were also present in
the human proteome map. Septin 7 was not detected in the
human lymphocyte proteome in that experiment, however, other
septins were identified [21].
(XLSX)
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